Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Free Cash Flow Generation Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥89.71 Million represents 1% of operating cash flow (CN¥110.78 Million). See Tianjin Zhongxin Pharmaceutical Group Co (600329) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Free Cash Flow Generation Index (2001–2024)
Historical FCF Generation Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Explore debt repayment capacity of Tianjin Zhongxin Pharmaceutical Group Co to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year Free Cash Flow Generation Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For the full company profile including market capitalisation, see Tianjin Zhongxin Pharmaceutical Group Co market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.87x | CN¥806.86 Million | CN¥924.67 Million | CN¥117.81 Million | ▲ +9.7% |
| 2023 | 0.80x | CN¥547.56 Million | CN¥688.49 Million | CN¥140.93 Million | ▼ -5.4% |
| 2022 | 0.84x | CN¥569.34 Million | CN¥677.25 Million | CN¥107.90 Million | ▲ +3.0% |
| 2021 | 0.82x | CN¥695.45 Million | CN¥852.40 Million | CN¥156.95 Million | ▲ +13.6% |
| 2020 | 0.72x | CN¥482.26 Million | CN¥671.42 Million | CN¥189.16 Million | ▲ +22.8% |
| 2019 | 0.59x | CN¥289.87 Million | CN¥495.49 Million | CN¥205.61 Million | ▲ +17.5% |
| 2018 | 0.50x | CN¥174.34 Million | CN¥350.14 Million | CN¥175.81 Million | ▼ -31.2% |
| 2016 | 0.72x | CN¥303.70 Million | CN¥419.90 Million | CN¥116.20 Million | ▼ -2.7% |
| 2015 | 0.74x | CN¥267.94 Million | CN¥360.58 Million | CN¥92.64 Million | ▼ -1.6% |
| 2014 | 0.76x | CN¥216.70 Million | CN¥286.85 Million | CN¥70.15 Million | ▲ +14.3% |
| 2013 | 0.66x | CN¥141.01 Million | CN¥213.44 Million | CN¥72.42 Million | ▲ +167.5% |
| 2012 | -0.98x | CN¥-20.37 Million | CN¥20.81 Million | CN¥41.18 Million | ▼ -230.0% |
| 2011 | 0.75x | CN¥130.86 Million | CN¥173.88 Million | CN¥43.02 Million | ▲ +49.0% |
| 2010 | 0.51x | CN¥70.25 Million | CN¥139.04 Million | CN¥68.79 Million | ▲ +1364.5% |
| 2009 | -0.04x | CN¥-3.33 Million | CN¥83.41 Million | CN¥86.74 Million | ▼ -105.3% |
| 2008 | 0.75x | CN¥117.40 Million | CN¥155.77 Million | CN¥38.36 Million | ▲ +145.2% |
| 2007 | -1.67x | CN¥-33.60 Million | CN¥20.13 Million | CN¥53.74 Million | ▼ -490.0% |
| 2005 | 0.43x | CN¥112.11 Million | CN¥261.91 Million | CN¥149.80 Million | ▲ +101.9% |
| 2004 | -23.04x | CN¥-241.81 Million | CN¥10.50 Million | CN¥252.31 Million | ▼ -244.1% |
| 2003 | -6.70x | CN¥-512.63 Million | CN¥76.57 Million | CN¥589.20 Million | ▼ -17523.4% |
| 2002 | 0.04x | CN¥7.21 Million | CN¥187.60 Million | CN¥180.40 Million | ▼ -74.5% |
| 2001 | 0.15x | CN¥23.77 Million | CN¥157.73 Million | CN¥133.95 Million | — |